Search
Atopic Dermatitis Clinical Trials in Charlotte, NC
A listing of 3 Atopic Dermatitis clinical trials in Charlotte, NC actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
The city of Charlotte, North Carolina, currently has 3 active clinical trials seeking participants for Atopic Dermatitis research studies.
Featured Trial
Atopic Dermatitis (Eczema) Study (Ages 12 to 17)
Recruiting
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Healthy Volunteer Trials
Recruiting
Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Healthy
Featured Trial
Atopic Dermatitis (Eczema) Study (Ages 12 to 17)
Recruiting
Featured Trial
Moderate to Severe Atopic Dermatitis Study
Recruiting
Conditions:
Atopic Dermatitis
Featured Trial
Atopic Dermatitis (Eczema) Study (Ages 18+)
Recruiting
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Gender:
All
Ages:
Between 12 years and 100 years
Trial Updated:
06/19/2024
Locations: Dermatology Specialists of Charlotte, Charlotte, North Carolina
Conditions: Atopic Dermatitis
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
Recruiting
This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
06/04/2024
Locations: AnaptysBio Investigative Site 10-109, Charlotte, North Carolina
Conditions: Atopic Dermatitis Eczema
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
Recruiting
Multicenter, randomized, double-blind, placebo-controlled, parallel arm clinical study designed to evaluate the efficacy and safety of eblasakimab in participants with moderate-to-severe atopic dermatitis (AD) previously treated with dupilumab.The study consists of a 16-week treatment period and an 8-week follow-up period up to Week 24. Eligible participants will be randomized into one of the 2 treatment arms.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/17/2024
Locations: ASLAN Investigative Site, Charlotte, North Carolina
Conditions: Atopic Dermatitis
1 - 3 of 3